+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology, Application, End User, and Country

  • ID: 4769907
  • Report
  • Region: Asia, Asia Pacific
  • 145 pages
  • The Insight Partners
1 of 4

FEATURED COMPANIES

  • Editas Medicine
  • GenScript
  • Lonza
  • Merck KGaA
  • New England Biolabs
  • MORE
The Asia Pacific genome editing market is expected to reach US$ 2,349.9 Mn in 2025 from US$ 673.3 Mn in 2017. The market is estimated to grow with a CAGR of 167.7% from 2018-2025.

The growth of the genome editing market is primarily attributed to the increase in funding for the genome editing and medical genetics in developing countries in the region. However, perception of the people for genetic alteration and tighten rules on gene editing are likely to pose a negative impact on the market growth. On the other hand, scopes for the consumer genomics is likely to have a positive impact on the growth of the Asia Pacific genome editing market in the coming years.

The market for the genome editing is expected to grow in the coming near future due to the growth factor that is driving the market majorly is increase in the funding. Owing to the advantages of the genome editing various government are supporting their public and private research and academic institutes for the increasing the research activities for the genome editing and genetic engineering. For instance, in the Asia Pacific region, the countries are also investing more for the development of the genome editing technology since two three years back. For instance, in April 2016, Japan invested approximately US$76million for the five years for the creation of Japanese owned genome editing technologies. The rise in the funding for the genome editing is likely to drive the market for the genome editing in the forecast period. The rise in the funding will enhance the research and development of the gene editing technologies and products for the researchers for efficient and effectively genome editing. The funding will also enable to the biopharmaceutical and pharmaceutical companies to develop technologies for the therapies using gene editing to treat and diagnose the chronic diseases.

In 2017, the CRISPR segment held a largest market share of 53.6% of the genome editing market, by technology. This segment is also expected to dominate the market in 2025 owing to the simple, fast and accurate property of the CRISPR. Moreover, the TALENs segment is anticipated to witness the significant growth rate of 17.7% during the forecast period, 2018 to 2025 owing to the properties provided by the TALENs the market for it is expected to rise in the coming near future.

Asia Pacific genome editing market, based on application was segmented into genetic engineering, cell line engineering and others. The cell line engineering segment is anticipated to grow at a CAGR of 18.6% during the forecast period. Moreover, the genetic engineering segment is expected to grow at the significant rate during the coming years owing to its sub segments such as animal genetic engineering and plant genetic engineering that are being carried out extensively.

In 2017, the biotechnology & pharmaceutical companies segment held a largest market share of 61.2% of the genome editing market, by end user. This segment is also expected to dominate the market in 2025 owing to the increasing in the development activities for the genome editing for the therapies and drug to treat genetic diseases. Hence, the market is likely to propel in the coming years.

Some of the major primary and secondary sources for genome editing included in the report are, Contract Research Organizations (CRO), Genomics R&D Initiative (GRDI), National Institutes of Health (NIH), Ministry of Science and Technology (MST), International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), Food and Drug Administration (FDA), Department of Biotechnology (DBT) and others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Editas Medicine
  • GenScript
  • Lonza
  • Merck KGaA
  • New England Biolabs
  • MORE
PART 1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 REPORT GUIDANCE

PART 2. ASIA PACIFIC GENOME EDITING TESTING MARKET - KEY TAKEAWAYS

PART 3. ASIA PACIFIC GENOME EDITING MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Asia Pacific Genome Editing Market - By Technology
3.2.2 Asia Pacific Genome Editing Market - By Application
3.2.3 Asia Pacific Genome Editing Market - By End User
3.2.4 Asia Pacific Genome Editing Market - By Country
3.3 PEST ANALYSIS

PART 4. ASIA PACIFIC GENOME EDITING MARKET- KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increase in Funding For The Genome Editing
4.1.2 Medical Genetics in Developing Countries
4.2 KEY MARKET RESTRAINTS
4.2.1 Perception of the People For Genetic Alteration
4.2.2 Tighten Rules On Gene Editing
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Gene Editing in Research Activities
4.4 FUTURE TRENDS
4.4.1 Rising Demand for CRISPR Cas9 Technology
4.5 IMPACT ANALYSIS

PART 5. GENOME EDITING MARKET - ASIA PACIFIC ANALYSIS
5.1 ASIA PACIFIC GENOME EDITING MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING
5.3 PERFORMANCE OF KEY PLAYERS
5.4 EXPERT OPINIONS

PART 6. ASIA PACIFIC GENOME EDITING MARKET ANALYSIS - BY TECHNOLOGY
6.1 OVERVIEW
6.2 ASIA PACIFIC GENOME EDITING MARKET, BY TECHNOLOGY, 2017 & 2025 (%)
6.3 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
6.4 TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) MARKET
6.4.1 Overview
6.4.2 Asia Pacific Transcription Activator-Like Effector Nucleases (TALENS) Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET
6.5.1 Overview
6.5.2 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 ZINC FINGER NUCLEASES (ZFNS) MARKET
6.6.1 Overview
6.6.2 Asia Pacific Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 ANTISENSE RNA MARKET
6.7.1 Overview
6.7.2 Asia Pacific Antisense RNA Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 OTHERS MARKET
6.8.1 Overview
6.8.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. ASIA PACIFIC GENOME EDITING MARKET ANALYSIS - BY APPLICATION
7.1 OVERVIEW
7.2 ASIA PACIFIC GENOME EDITING MARKET, BY APPLICATION, 2017 & 2025 (%)
7.3 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
7.4 GENETIC ENGINEERING MARKET
7.4.1 Overview
7.4.2 Asia Pacific Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.4.3 Animal Genetic Engineering Market
7.4.3.1 Overview
7.4.3.2 Asia Pacific Animal Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.4.4 Plant Genetic Engineering Market
7.4.4.1 Overview
7.4.4.2 Asia Pacific Plant Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CELL LINE ENGINEERING MARKET
7.5.1 Overview
7.5.2 Asia Pacific Cell Line Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 OTHERS MARKET
7.6.1 Overview
7.6.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. ASIA PACIFIC GENOME EDITING MARKET ANALYSIS - BY END USER
8.1 OVERVIEW
8.2 ASIA PACIFIC GENOME EDITING MARKET, BY END USER, 2017 & 2025 (%)
8.3 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
8.4 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET
8.4.1 Overview
8.4.2 Asia Pacific Biotechnology & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 ACADEMIC & GOVERNMENT RESEARCH ORGANIZATIONS MARKET
8.5.1 Overview
8.5.2 Asia Pacific Academic & Government Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn)
8.6 CONTRACT RESEARCH ORGANIZATION MARKET
8.6.1 Overview
8.6.2 Asia Pacific Contract Research Organization Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025
9.1 OVERVIEW
9.2 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.3 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY(US$ MN)
9.4 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
9.4.1 Asia Pacific Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.5 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
9.6 ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
9.7 CHINA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.7.1 China Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 China Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
9.7.3 China Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.7.3.1 China Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.7.4 China Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
9.8 JAPAN GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.8.1 Japan Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Japan Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
9.8.3 Japan Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8.3.1 Japan Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.8.4 Japan Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
9.9 INDIA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.9.1 India Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 India Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
9.9.3 India Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9.3.1 India Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.9.4 India Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

PART 10. GENOME EDITING MARKET-KEY COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC INC.
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 INTEGRATED DNA TECHNOLOGIES, INC.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 MERCK KGAA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT ANALYSIS
10.3.6 KEY DEVELOPMENTS
10.4 LONZA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 NEW ENGLAND BIOLABS
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 GENSCRIPT
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product/ Services Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 HORIZON DISCOVERY GROUP PLC
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product/ Services Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 SANGAMO THERAPEUTICS, INC.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 EDITAS MEDICINE
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments

PART 11. APPENDIX
11.1 ABOUT THE PUBLISHER
11.2 GLOSSARY OF TERMS
11.3 METHODOLOGY
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research

LIST OF TABLES
TABLE 1. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 2. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 3. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 4. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 5. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 6. ASIA PACIFIC GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 7. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 8. CHINA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 9. CHINA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 10. CHINA GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 11. CHINA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 12. JAPAN GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 13. JAPAN GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 14. JAPAN GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 15. JAPAN GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 16. INDIA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 17. INDIA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 18. INDIA GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 19. INDIA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 20. GLOSSARY OF TERMS, GENOME EDITING MARKET

LIST OF FIGURES
FIGURE 1. CHINA GENOME EDITING MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025
FIGURE 2. ASIA PACIFIC GENOME EDITING MARKET BY TYPE, MARKET SHARE (%), 2017
FIGURE 3. ASIA PACIFIC GENOME EDITING MARKET BY SERVICES, MARKET SHARE (%), 2017
FIGURE 4. ASIA PACIFIC GENOME EDITING MARKET BY END USER, MARKET SHARE (%), 2017
FIGURE 5. GENOME EDITING MARKET SEGMENTATION
FIGURE 6. ASIA PACIFIC PEST ANALYSIS
FIGURE 7. GENOME EDITING MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 8. ASIA PACIFIC GENOME EDITING MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
FIGURE 9. ASIA PACIFIC GENOME EDITING MARKET, BY TECHNOLOGY, 2017 & 2025 (%)
FIGURE 10. ASIA PACIFIC TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 11. ASIA PACIFIC CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 12. ASIA PACIFIC ZINC FINGER NUCLEASES (ZFNS) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 13. ASIA PACIFIC ANTISENSE RNA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 14. ASIA PACIFIC OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 15. ASIA PACIFIC GENOME EDITING MARKET BY APPLICATION, 2017 & 2025 (%)
FIGURE 16. ASIA PACIFIC GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 17. ASIA PACIFIC ANIMAL GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 18. ASIA PACIFIC PLANT GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 19. ASIA PACIFIC CELL LINE ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 20. ASIA PACIFIC OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. ASIA PACIFIC GENOME EDITING MARKET BY END USER, 2017 & 2025 (%)
FIGURE 22. ASIA PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 23. ASIA PACIFIC ACADEMIC & GOVERNMENT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025
(US$ MN)
FIGURE 24. ASIA PACIFIC CONTRACT RESEARCH ORGANIZATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 25. ASIA PACIFIC GENOME EDITING MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
FIGURE 26. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 27. ASIA PACIFIC GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 28. CHINA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 29. JAPAN GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 30. INDIA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Transposagen Biopharmaceuticals, Inc.
  • Integrated DNA Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • GenScript
  • Lonza
  • Horizon Discovery Group plc
  • Sangamo Therapeutics, Inc.
  • New England Biolabs
  • Editas Medicine
  • Merck KGaA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769907
Adroll
adroll